Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

Haemostatix

Haemostatix

Home > Investment> Haemostatix

Haemostatix developed a number of haemostatic products including their lead product PeprostatTM, a topical haemostat for the treatment of bleeding during surgery. Hemostatix is now a wholly own subsidiary of Ergomed following the acquisition in May 2016.